TICKERNOMICS Sign up
Last Update: 2024-03-28 02:12:40
biote Corp. ( BTMD ) https://biote.com
5.89USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
BTMD
24.52%
SPY
32.74%
BTMD
0.00%
SPY
92.93%
BTMD
0.00%
SPY
224.41%
BTMD
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
182.83
275.71
0.11
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-29.33
0.99
-5.00
9.79
0.00
8.45
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
16.68
68.90
17.63
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
14.50
26.90
0.00
Other Earnings and Cash Flow Stats:
biote Corp. ( BTMD ) Net Income TTM ($MM) is -7.44
biote Corp. ( BTMD ) Operating Income TTM ($MM) is 30.60
biote Corp. ( BTMD ) Owners' Earnings Annual ($MM) is 0.00
biote Corp. ( BTMD ) Current Price to Owners' Earnings ratio is 0.00
biote Corp. ( BTMD ) EBITDA TTM ($MM) is 33.03
biote Corp. ( BTMD ) EBITDA Margin is 17.63%
Capital Allocation:
biote Corp. ( BTMD ) has paid 0.00 dividends per share and bought back -22.981874 million shares in the past 12 months
biote Corp. ( BTMD ) has reduced its debt by 13.963 million USD in the last 12 months
Capital Structure:
biote Corp. ( BTMD ) Interest-bearing Debt ($MM) as of last quarter is 112
biote Corp. ( BTMD ) Annual Working Capital Investments ($MM) are -17
biote Corp. ( BTMD ) Book Value ($MM) as of last quarter is -37
biote Corp. ( BTMD ) Debt/Capital as of last quarter is -384%
Other Balance Sheet Stats:
biote Corp. ( BTMD ) has 89 million in cash on hand as of last quarter
biote Corp. ( BTMD ) has 22 million of liabilities due within 12 months, and long term debt 112 as of last quarter
biote Corp. ( BTMD ) has 31 common shares outstanding as of last quarter
biote Corp. ( BTMD ) has 0 million USD of preferred stock value
Academic Scores:
biote Corp. ( BTMD ) Altman Z-Score is 2.93 as of last quarter
biote Corp. ( BTMD ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
biote Corp. ( BTMD ) largest shareholder is Acadian Asset Management LLC owning 139565 shares at 0.82 ($MM) value
Mary Elizabeth Conlon(an insider) Sold 6240 shares of biote Corp. ( BTMD ) for the amount of $40560.00 on 2023-07-05
16.38% of biote Corp. ( BTMD ) is held by insiders, and 71.43% is held by institutions
biote Corp. ( BTMD ) went public on 2021-04-28
Other biote Corp. ( BTMD ) financial metrics:
FCF:24.03
Unlevered Free Cash Flow:47.75
EPS:0.97
Operating Margin:16.68
Gross Profit Margin:68.90
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-102.46
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About biote Corp. ( BTMD ) :
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine, Texas.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.